Siri Advisory works with leading companies in Healthcare sector especially pharmaceutical, Speciality Chemical and bio-tech companies to help develop the fundamentals for future growth and develop the effectiveness and efficiency of their current business operations. We work side by side with our clients for becoming future market leaders by focusing on important priorities that will make them swift and adaptable to attractive market opportunities, including:

Advising on Acquisition and post acquisition integration

• Successful Pharma companies avoid consequences that can undercut an acquisition by customising the integration and deal thesis, integrating where it matters, acting quickly to create shareholders value and guide in setting up high-growth trajectory.

  Addressing cost efficiency and advising cost-effective business models

• Pharma companies need to change their business models to significantly increase their return on sales. We recommend financial redesigning and reengineering to our clients for cost effectiveness and improve profitability.